×

Kiwa Bio-Tech Reminds Shareholders to Vote Their Proxy

CLAREMONT, Calif., Nov. 19, 2015 (GLOBE NEWSWIRE) -- Kiwa Bio-Tech Products Group Corporation (OTCBB:KWBT) reminded shareholders today to vote their form of proxy of the Company’s Annual Meeting of Shareholders to be held on Nov 20, 2015. The record date for determinations of shareholders entitle to vote at the annual meeting is October 12, 2015.

The Annual General Meeting of shareholders is scheduled for Friday, Nov 20, 2015 at 10:00 am local time at Kiwa’s Beijing office. The company urges all shareholders to vote their form of proxy for all proposed resolutions.

Your vote is extremely important and it is highly recommended to vote via telephone or Internet.

About Kiwa Bio-Tech Products Group Corporation

We develop, manufacture, distribute and market innovative, cost-effective and eco-friendly bio-technological products for agriculture. Our main product groups are bio-fertilizer, biologically enhanced livestock feed. Our products are designed to enhance the quality of human life by increasing the value, quality and productivity of crops and decreasing the negative environmental impact of chemicals and other wastes. Our businesses include bio-fertilizer and bio-enhanced feed.

Kiwa’s new strategy is to implement top-vision planning for marketing Kiwa’s current bio-fertilizer products, along with the construction of a “green agriculture” safe food platform in China. Our goal is to build market trust in our Kiwa brand, gradually entering China’s trillion dollar “green” agricultural produce market.

For more information on Kiwa and its products, please refer to the website at www.kiwabiotech.com or the Company filings with the United States Security and Exchange Commission, available for free at www.sec.gov.

This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.

CONTACT: Kiwa Bio-Tech Products Group Corporation Yvonne Wang (626) 715-5855 yvonne@kiwabiotech.com

Source:Kiwa Bio-Tech Products Group Corporation